Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, Nicholas C.P. Cross. Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. Haematologica 2013;98(3):404-408; https://doi.org/10.3324/haematol.2012.067959.